Author

P. Romero

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Cancer Biology· 1 Plant Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Assay:bulk RNA-seq· 3 Research Focus:cell type annotation· 3 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell signaling & trafficking· 2 Assay:proteomics· 2 Research Focus:cell-cell communication· 1

Frequent Co-Authors

A. Charap· 1 shared A. Hamza· 1 shared A. Luscan· 1 shared A. M. Farkas· 1 shared A. Michaud· 1 shared A. O. Kamphorst· 1 shared A. Santiago· 1 shared A. Spill· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Charap

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition

P. Romero, L. Richart, S. Aflaki, M. Burton, A. Michaud, J. Masliah-Planchon, F. Kuhnoswki, C. Meaudre, A. Luscan, A. Hamza, P. Legoix, A. Vincent-Salomon, M. Wassef, D. Holoch, R. Margueron

This study shows that EZH2 mutations in follicular lymphoma alter H3K27 methylation and transcriptional responses to PRC2 inhibition, with clinical implications for patient stratification.

bioRxiv · Jan 2, 2023Cancer Biology

NKG2A and HLA-E define a novel alternative immune checkpoint axis in bladder cancer

B. Salome, J. P. Sfakianos, J. Daza, A. Charap, C. Hammer, R. Banchereau, A. M. Farkas, D. Geanon, G. Kelly, R. M. de Real, B. Lee, K. G. Beaumont, S. Shroff, Y. S. A. Wang, Y.-C. Wang, , Mariath

This study identifies NKG2A and HLA-E as an alternative immune checkpoint axis in bladder cancer, showing NKG2A+ CD8 T cells can bypass HLA-ABC loss through TCR-independent cytotoxicity.

bioRxiv · Mar 4, 2022 · PreprintImmunology

Orthogonal Gene Engineering Enables CD8+ T Cells to Control Tumors through a Novel PD-1+ TOX-indifferent Synthetic Effector State

J. Corria-Osorio, S. J. Carmona, E. Stefanidis, M. J. Andreatta, T. Muller, Y. Ortiz, B. Seijo, W. Castro, C. Jimenez-Luna, L. Scarpellino, C. Ronet, A. Spill, E. Lanitis, S. A. Luther, P. Romero, , G. Coukos

This study shows that orthogonal gene engineering of CD8+ T cells with IL-2 variant, PD1-decoy, and IL-33 enables tumor control through a novel PD-1+ TOX-indifferent synthetic effector state.

bioRxiv · Feb 18, 2022 · PreprintImmunology

Major orchestration of shikimate, early phenylpropanoid and stilbenoid pathways by Subgroup 2 R2R3-MYBs in grapevine

L. Orduna, M. Li, D. Navarro-Paya, C. Zhang, A. Santiago, P. Romero, Z. Ramsak, G. Magon, J. Höll, P. Merz, K. Gruden, A. Vannozzi, D. Cantu, J. Bogs, D. C. J. Wong, , J. T. Matus

This study identifies Subgroup 2 R2R3-MYBs as key regulators of the stilbenoid pathway in grapevine by integrating DAP-Seq and co-expression networks.

bioRxiv · Dec 31, 2020 · PreprintPlant Biology

Lack of mucosal cholinergic innervation is associated with increased risk of enterocolitis in Hirschsprung disease

S. Keck, V. Galati-Fournier, U. Kym, M. Moesch, J. Usemann, U. Subotic, S. Tharakan, T. Krebs, E. Stathopoulos, P. Schmittenbecher, D. Cholewa, P. Romero, B. Reingruber, E. Bruder, NIG Study Group, S. Holland-Cunz

This study shows that lack of mucosal cholinergic innervation in Hirschsprung disease patients increases the risk of postoperative enterocolitis.

bioRxiv · Jun 15, 2020Immunology